2021 · Devices & clinical
Neuroform Atlas Stent for Treatment of Middle Cerebral Artery Aneurysms: 1-Year Outcomes From Neuroform Atlas Stent Pivotal Trial
Hanel RA, Yoon N, Sauvageau E, Aghaebrahim A, Lin E, Jadhav AP, Jovin TG, Khaldi A, Gupta RG, Johnson A, Frei D, Loy D, Malek A, Toth G, Siddiqui A, Reavey-Cantwell J, Thomas A, Hetts SW, Jankowitz BT, Zaidat OO.
Neurosurgery 89(1):102-108, 2021.
PMID 33826707 · DOI 10.1093/neuros/nyab090
In plain language
Results of catheter treatment for aneurysms vary by location in the brain, and little data existed on using a stent to support coils in aneurysms of the middle cerebral artery, a vessel supplying a large part of the brain. This report covers those patients from the Neuroform Atlas stent trial.

Thirty five patients with wide necked aneurysms were treated, average size 6.0 millimeters, and the procedure was technically successful in every one. Of the 26 patients with angiography at 12 months, 21 (80.8 percent) had complete closure. Three of 35 patients (8.5 percent) had a major ischemic stroke, and at one year 27 of 32 patients (84.4 percent) were living independently or with only slight disability.
With careful patient selection, the authors see this as a reasonable alternative to surgical clipping.
A plain-language summary for patients and families. It is not medical advice, and individual results vary.
Abstract
Background
Heterogeneous effect of endovascular aneurysm therapy has been observed across different anatomic locations. There is a paucity of data for stent-assisted coiling of middle cerebral artery (MCA) aneurysms.
Objective
To present the results of the MCA aneurysm group from the Neuroform Atlas (Stryker Neurovascular) investigational device exemption (IDE) trial.
Methods
The Atlas IDE trial is a prospective, multicenter, single-arm, open-label study of wide-neck aneurysms (neck ≥ 4 mm or dome-to-neck ratio < 2) in the anterior circulation treated with the Neuroform Atlas Stent and approved coils. Follow-up was obtained immediately postprocedure and 2, 6, and 12 mo postoperatively. We herein describe safety and efficacy outcomes, and functional independence of the subjects with aneurysms from all segments of MCA.
Results
A total of 35 patients were included (27 MCA bifurcation, 5 M1, 3 M2). The mean aneurysm size was 6.0 ± 1.8 mm, and the mean neck was 4.4 ± 1.2 mm. Technical procedural success was achieved in all patients. A total of 26 patients had follow-up digital subtraction angiography available at 12 mo, with 80.8% (21/26) having complete aneurysm occlusion. Twelve-month safety data were collected for 91.4% (32/35), 8.5% (3/35) had primary safety endpoint, all 3 major ischemic strokes. Mortality occurred in 2 patients beyond 30 d unrelated to procedure (1 gallbladder cancer and 1 fentanyl intoxication). At 1 yr, modified Rankin Score was 0 to 2 in 84.4% (27/32), 3 in 9.4%, and 3 patients were missing. Approximately 5.7% (2/35) of patients were retreated at 12 mo.
Conclusion
Stent-assisted coiling with the Neuroform Atlas Stent is a viable alternative to clipping for selected MCA aneurysms. Complete aneurysm occlusion rates have improved compared to historical data. Proper case selection can lead to acceptable endovascular results.
Abstract as indexed in PubMed (PMID 33826707). Copyright the publisher.
Cite this paper
Hanel RA, Yoon N, Sauvageau E, Aghaebrahim A, Lin E, Jadhav AP, Jovin TG, Khaldi A, Gupta RG, Johnson A, Frei D, Loy D, Malek A, Toth G, Siddiqui A, Reavey-Cantwell J, Thomas A, Hetts SW, Jankowitz BT, Zaidat OO. Neuroform Atlas Stent for Treatment of Middle Cerebral Artery Aneurysms: 1-Year Outcomes From Neuroform Atlas Stent Pivotal Trial. Neurosurgery 89(1):102-108. 2021. doi:10.1093/neuros/nyab090 PMID: 33826707.